Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
J Ocul Pharmacol Ther. 2023 Dec;39(10):692-698. doi: 10.1089/jop.2023.0063. Epub 2023 Aug 11.
Dry eye disease (DED) is a multifactorial disease affecting 5% to 50% in different populations. The most severe cases of DED are often caused by aqueous deficient dry eye disease (ADDE) due to lacrimal gland (LG) hypofunction. Many patients with severe ADDE do not experience adequate symptom relief from topical treatment, severely reducing their quality of life. The focus of this review is to describe the surgical interventions presently being used or investigated when topical treatment with eye drops is insufficient. The conventional surgical approach is to proceed to punctal occlusion or partial or total tarsorrhaphy. However, novel surgical procedures have been reported to have higher efficacy and patient satisfaction than conventional treatments. These procedures include amniotic membrane transplantation, transposition or transplantation of the salivary glands, and cell-based injections into the LG, each with strengths and weaknesses. Further development of these treatment modalities might prove pivotal in treating dry eye patients in the future.
干眼症(DED)是一种多因素疾病,在不同人群中的发病率为 5%至 50%。DED 最严重的情况通常是由于泪腺(LG)功能低下导致的水样液缺乏性干眼症(ADDE)。许多患有严重 ADDE 的患者通过局部滴眼治疗无法获得足够的症状缓解,严重降低了他们的生活质量。本综述的重点是描述在局部滴眼治疗不足时目前正在使用或研究的手术干预措施。传统的手术方法是进行泪点闭塞或部分或全部睑缘缝合术。然而,已经有报道称一些新型手术程序比传统治疗方法具有更高的疗效和患者满意度。这些程序包括羊膜移植、唾液腺转位或移植以及向 LG 内注射细胞,每种方法都有其优缺点。这些治疗方式的进一步发展可能对未来治疗干眼症患者具有重要意义。